133 related articles for article (PubMed ID: 17216639)
21. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D
Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197
[TBL] [Abstract][Full Text] [Related]
22. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
23. LRRK2 R1441G in Spanish patients with Parkinson's disease.
Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
[TBL] [Abstract][Full Text] [Related]
24. Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease.
Tan EK; Lee J; Chen CP; Wong MC; Zhao Y
Neurobiol Aging; 2009 Mar; 30(3):501-2. PubMed ID: 17720280
[TBL] [Abstract][Full Text] [Related]
25. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
[TBL] [Abstract][Full Text] [Related]
26. LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan.
Miyake Y; Tsuboi Y; Koyanagi M; Fujimoto T; Shirasawa S; Kiyohara C; Tanaka K; Fukushima W; Sasaki S; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
J Neurol Sci; 2010 Oct; 297(1-2):15-8. PubMed ID: 20673920
[TBL] [Abstract][Full Text] [Related]
27. Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.
Mata IF; Wilhoite GJ; Yearout D; Bacon JA; Cornejo-Olivas M; Mazzetti P; Marca V; Ortega O; Acosta O; Cosentino C; Torres L; Medina AC; Perez-Pastene C; Díaz-Grez F; Vilariño-Güell C; Venegas P; Miranda M; Trujillo-Godoy O; Layson L; Avello R; Dieguez E; Raggio V; Micheli F; Perandones C; Alvarez V; Segura-Aguilar J; Farrer MJ; Zabetian CP; Ross OA
Parkinsonism Relat Disord; 2011 Sep; 17(8):629-31. PubMed ID: 21632271
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
[TBL] [Abstract][Full Text] [Related]
29. LRRK2 mutations in a clinic-based cohort of Parkinson's disease.
Scholz S; Mandel RJ; Fernandez HH; Foote KD; Rodriguez RL; Barton E; Munson S; Singleton A; Okun MS
Eur J Neurol; 2006 Dec; 13(12):1298-301. PubMed ID: 17116211
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.
Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok J; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio JP; Sue CM
Mov Disord; 2007 May; 22(7):982-9. PubMed ID: 17427941
[TBL] [Abstract][Full Text] [Related]
31. Clinical heterogeneity of the LRRK2 G2019S mutation.
Papapetropoulos S; Singer C; Ross OA; Toft M; Johnson JL; Farrer MJ; Mash DC
Arch Neurol; 2006 Sep; 63(9):1242-6. PubMed ID: 16966501
[TBL] [Abstract][Full Text] [Related]
32. Lrrk2 pathogenic substitutions in Parkinson's disease.
Mata IF; Kachergus JM; Taylor JP; Lincoln S; Aasly J; Lynch T; Hulihan MM; Cobb SA; Wu RM; Lu CS; Lahoz C; Wszolek ZK; Farrer MJ
Neurogenetics; 2005 Dec; 6(4):171-7. PubMed ID: 16172858
[TBL] [Abstract][Full Text] [Related]
33. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.
Taylor JP; Hulihan MM; Kachergus JM; Melrose HL; Lincoln SJ; Hinkle KM; Stone JT; Ross OA; Hauser R; Aasly J; Gasser T; Payami H; Wszolek ZK; Farrer MJ
Neurogenetics; 2007 Apr; 8(2):95-102. PubMed ID: 17225181
[TBL] [Abstract][Full Text] [Related]
34. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
[TBL] [Abstract][Full Text] [Related]
35. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.
Hernandez DG; Paisán-Ruíz C; McInerney-Leo A; Jain S; Meyer-Lindenberg A; Evans EW; Berman KF; Johnson J; Auburger G; Schäffer AA; Lopez GJ; Nussbaum RL; Singleton AB
Ann Neurol; 2005 Mar; 57(3):453-6. PubMed ID: 15732108
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
[TBL] [Abstract][Full Text] [Related]
37. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A
Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909
[TBL] [Abstract][Full Text] [Related]
38. A study of LRRK2 mutations and Parkinson's disease in Brazil.
Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
[TBL] [Abstract][Full Text] [Related]
39. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
Gosal D; Lynch T; Ross OA; Haugarvoll K; Farrer MJ; Gibson JM
Mov Disord; 2007 Jan; 22(2):291-2. PubMed ID: 17089395
[No Abstract] [Full Text] [Related]
40. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease.
Funalot B; Nichols WC; Pérez-Tur J; Mercier G; Lucotte G
Genet Test; 2006; 10(4):290-3. PubMed ID: 17253937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
